| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | prolactin receptor binding | 2.18e-05 | 7 | 173 | 3 | GO:0005148 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 7.33e-05 | 10 | 173 | 3 | GO:0005131 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 1.62e-04 | 32 | 173 | 4 | GO:0099186 | |
| GeneOntologyBiologicalProcess | proline transport | 3.01e-06 | 13 | 170 | 4 | GO:0015824 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | EPHB3 NRDC DSCAM ENPP2 CAMK2B NEFL LIG4 MEGF8 CSH1 CSH2 CSHL1 LRRTM4 DLG4 | 4.53e-05 | 418 | 170 | 13 | GO:0051962 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB3 COL6A1 NRDC DSCAM MAP2 MYCBP2 ENPP2 CAMK2B TRPC6 SHROOM2 CRK STRIP2 NEFL FAT1 MEGF8 NFIA DLG1 DLG4 SEMA6A RERE PLEC PRDM14 HCK PHACTR1 | 4.66e-05 | 1194 | 170 | 24 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB3 IL10RA COL17A1 DSCAM MYCBP2 ENPP2 CAMK2B PKP4 SH3BP1 SHROOM2 CRK ACE2 NEFL NFIA VPS35 LRRTM4 ARHGEF9 DLG1 KIRREL1 DLG4 PLEC | 5.41e-05 | 974 | 170 | 21 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | EPHB3 NRDC DSCAM MAP2 ENPP2 CAMK2B TRPC6 NEFL LIG4 MEGF8 CSH1 CSH2 CSHL1 LRRTM4 DLG1 DLG4 | 6.25e-05 | 625 | 170 | 16 | GO:0051960 |
| GeneOntologyBiologicalProcess | cell junction assembly | EPHB3 COL17A1 DSCAM MYCBP2 ENPP2 PKP4 SH3BP1 CRK ACE2 VPS35 LRRTM4 ARHGEF9 DLG1 DLG4 PLEC | 7.72e-05 | 569 | 170 | 15 | GO:0034329 |
| GeneOntologyBiologicalProcess | proline transmembrane transport | 8.65e-05 | 11 | 170 | 3 | GO:0035524 | |
| GeneOntologyCellularComponent | calcium- and calmodulin-dependent protein kinase complex | 5.13e-06 | 5 | 169 | 3 | GO:0005954 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 1.02e-05 | 6 | 169 | 3 | GO:0070195 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | SEL1L MAPKAP1 KANSL1L EP400 CAMK2B CAMK2D POLE CAMK2G ZNFX1 PSME2 NCBP2 LIG4 FBXL16 MEGF8 MORF4L2 CTR9 UBR3 GAN DGCR8 CCT8L1P SLX4 | 3.97e-05 | 972 | 169 | 21 | GO:0140535 |
| GeneOntologyCellularComponent | endocytic vesicle membrane | CAMK2B CAMK2D CAMK2G PIK3R4 ACE2 CACNG8 SLC15A2 DLG4 RAB11FIP3 | 5.89e-05 | 212 | 169 | 9 | GO:0030666 |
| GeneOntologyCellularComponent | postsynaptic density | MAP2 CAMK2B CAMK2G PKP4 HNRNPH1 HNRNPH2 CACNG8 VPS35 LRRTM4 ARHGEF9 DLG1 DLG4 DGCR8 | 8.04e-05 | 451 | 169 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | MAP2 CAMK2B CAMK2G PKP4 HNRNPH1 HNRNPH2 CACNG8 VPS35 LRRTM4 ARHGEF9 DLG1 DLG4 DGCR8 | 1.40e-04 | 477 | 169 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | MAP2 CAMK2B CAMK2G PKP4 HNRNPH1 HNRNPH2 CACNG8 VPS35 LRRTM4 ARHGEF9 DLG1 DLG4 DGCR8 | 2.36e-04 | 503 | 169 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | neuromuscular junction | 3.01e-04 | 112 | 169 | 6 | GO:0031594 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.31e-04 | 114 | 169 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | MAP2 CAMK2B CAMK2G PKP4 HNRNPH1 HNRNPH2 CACNG8 VPS35 LRRTM4 ARHGEF9 DLG1 DLG4 DGCR8 | 3.42e-04 | 523 | 169 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | cation channel complex | 6.70e-04 | 235 | 169 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 7.85e-04 | 185 | 169 | 7 | GO:0009898 | |
| GeneOntologyCellularComponent | sarcolemma | 9.17e-04 | 190 | 169 | 7 | GO:0042383 | |
| GeneOntologyCellularComponent | anchoring junction | FLII FLNC RPGRIP1L COL17A1 CAMK2D PKP4 TRPC6 SH3BP1 SHROOM2 AFAP1L1 FAT1 KCNA5 DLG1 KIRREL1 DLG4 PLEC KDF1 HCK | 9.57e-04 | 976 | 169 | 18 | GO:0070161 |
| GeneOntologyCellularComponent | dendritic branch | 1.33e-03 | 7 | 169 | 2 | GO:0044307 | |
| MousePheno | abnormal forebrain morphology | RPGRIP1L NRDC DSCAM MAP2 RASA3 MYCBP2 ENPP2 PEG3 HIPK2 MARCHF7 POGZ LBR S1PR1 MKS1 PIK3R4 NEFL LIG4 CACNG8 IPO9 PPT2 CSH1 CSH2 CSHL1 NFIA VPS35 LRRTM4 MAST1 DLG4 SEMA6A DGCR8 RERE SPAG17 SLX4 | 9.54e-08 | 1072 | 158 | 33 | MP:0000783 |
| MousePheno | abnormal cerebral hemisphere morphology | RPGRIP1L NRDC DSCAM MAP2 MYCBP2 MARCHF7 POGZ MKS1 PIK3R4 NEFL LIG4 CACNG8 PPT2 NFIA LRRTM4 MAST1 DLG4 SEMA6A DGCR8 RERE SLX4 | 3.88e-06 | 599 | 158 | 21 | MP:0008540 |
| MousePheno | abnormal telencephalon morphology | RPGRIP1L NRDC DSCAM MAP2 MYCBP2 MARCHF7 POGZ LBR S1PR1 MKS1 PIK3R4 NEFL LIG4 CACNG8 PPT2 NFIA LRRTM4 MAST1 DLG4 SEMA6A DGCR8 RERE SPAG17 SLX4 | 1.38e-05 | 812 | 158 | 24 | MP:0000787 |
| Domain | CaMKII_AD | 2.89e-06 | 4 | 169 | 3 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 2.89e-06 | 4 | 169 | 3 | IPR013543 | |
| Domain | SOMATOTROPIN_2 | 1.43e-05 | 6 | 169 | 3 | PS00338 | |
| Domain | SOMATOTROPIN_1 | 1.43e-05 | 6 | 169 | 3 | PS00266 | |
| Domain | Hormone_1 | 1.43e-05 | 6 | 169 | 3 | PF00103 | |
| Domain | Somatotropin | 2.48e-05 | 7 | 169 | 3 | IPR001400 | |
| Domain | - | 1.95e-04 | 13 | 169 | 3 | 3.10.450.50 | |
| Domain | Znf_CHHC | 2.43e-04 | 3 | 169 | 2 | IPR012996 | |
| Domain | CHD_N | 2.43e-04 | 3 | 169 | 2 | IPR012958 | |
| Domain | CHD_C2 | 2.43e-04 | 3 | 169 | 2 | IPR012957 | |
| Domain | CHDCT2 | 2.43e-04 | 3 | 169 | 2 | PF08074 | |
| Domain | CHDNT | 2.43e-04 | 3 | 169 | 2 | PF08073 | |
| Domain | DUF1086 | 2.43e-04 | 3 | 169 | 2 | IPR009462 | |
| Domain | DUF1087 | 2.43e-04 | 3 | 169 | 2 | IPR009463 | |
| Domain | zf-RNPHF | 2.43e-04 | 3 | 169 | 2 | PF08080 | |
| Domain | DUF1087 | 2.43e-04 | 3 | 169 | 2 | PF06465 | |
| Domain | DUF1086 | 2.43e-04 | 3 | 169 | 2 | PF06461 | |
| Domain | DUF1087 | 2.43e-04 | 3 | 169 | 2 | SM01147 | |
| Domain | DUF1086 | 2.43e-04 | 3 | 169 | 2 | SM01146 | |
| Domain | NTF2-like_dom | 3.06e-04 | 15 | 169 | 3 | IPR032710 | |
| Domain | MAGUK_N_PEST | 4.83e-04 | 4 | 169 | 2 | PF10608 | |
| Domain | PDZ_assoc | 4.83e-04 | 4 | 169 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 4.83e-04 | 4 | 169 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 4.83e-04 | 4 | 169 | 2 | IPR019583 | |
| Domain | DUF1908 | 4.83e-04 | 4 | 169 | 2 | PF08926 | |
| Domain | MA_Ser/Thr_Kinase_dom | 4.83e-04 | 4 | 169 | 2 | IPR015022 | |
| Domain | MAGUK_N_PEST | 4.83e-04 | 4 | 169 | 2 | SM01277 | |
| Domain | DLG1 | 4.83e-04 | 4 | 169 | 2 | IPR016313 | |
| Domain | MAST_pre-PK_dom | 4.83e-04 | 4 | 169 | 2 | IPR023142 | |
| Domain | - | 4.83e-04 | 4 | 169 | 2 | 1.20.1480.20 | |
| Domain | Somatotropin_CS | 8.00e-04 | 5 | 169 | 2 | IPR018116 | |
| Domain | ConA-like_dom | 8.74e-04 | 219 | 169 | 8 | IPR013320 | |
| Domain | PROTEIN_KINASE_ATP | EPHB3 EPHB4 CAMK2B CAMK2D CAMK2G HIPK2 PIK3R4 MAST4 MARK4 MAST1 MAP3K15 HCK | 9.87e-04 | 459 | 169 | 12 | PS00107 |
| Domain | TRP_2 | 1.19e-03 | 6 | 169 | 2 | PF08344 | |
| Domain | TRP_dom | 1.19e-03 | 6 | 169 | 2 | IPR013555 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 1.51e-08 | 20 | 125 | 6 | M17670 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.10e-08 | 21 | 125 | 6 | M838 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION | 2.10e-08 | 21 | 125 | 6 | M27944 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.86e-08 | 22 | 125 | 6 | MM15104 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 3.84e-08 | 23 | 125 | 6 | M27949 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 1.38e-07 | 28 | 125 | 6 | M837 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.73e-07 | 29 | 125 | 6 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.65e-07 | 31 | 125 | 6 | M7223 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 5.67e-07 | 35 | 125 | 6 | MM15109 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.31e-06 | 44 | 125 | 6 | M27934 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.28e-06 | 144 | 125 | 9 | MM14501 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 8.41e-06 | 32 | 125 | 5 | M27900 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CAMK2B CAMK2D CAMK2G SLC38A2 NEFL CACNG8 KCNA5 KCNA7 GNB5 LRRTM4 ARHGEF9 DLG1 DLG4 | 8.54e-06 | 335 | 125 | 13 | MM14503 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | CAMK2B CAMK2D CAMK2G SLC38A2 NEFL CACNG8 GNB5 ARHGEF9 DLG1 DLG4 | 1.81e-05 | 211 | 125 | 10 | MM14502 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 1.94e-05 | 63 | 125 | 6 | M27862 | |
| Pathway | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | 2.56e-05 | 20 | 125 | 4 | MM15070 | |
| Pathway | WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION | 5.76e-05 | 47 | 125 | 5 | M39531 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | CAMK2B CAMK2D CAMK2G SLC38A2 NEFL CACNG8 KCNA5 KCNA7 GNB5 LRRTM4 ARHGEF9 DLG1 DLG4 | 7.22e-05 | 411 | 125 | 13 | M735 |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 7.80e-05 | 10 | 125 | 3 | M26910 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 8.71e-05 | 205 | 125 | 9 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | CAMK2B CAMK2D CAMK2G SLC38A2 NEFL CACNG8 GNB5 ARHGEF9 DLG1 DLG4 | 1.44e-04 | 270 | 125 | 10 | M15514 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.75e-04 | 32 | 125 | 4 | M27455 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.82e-04 | 13 | 125 | 3 | MM14516 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.86e-04 | 94 | 125 | 6 | M2843 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.98e-04 | 33 | 125 | 4 | M39875 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.31e-04 | 14 | 125 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 2.31e-04 | 14 | 125 | 3 | M47388 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 2.86e-04 | 15 | 125 | 3 | M47385 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 3.50e-04 | 16 | 125 | 3 | MM15710 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_METABOLISM | 3.86e-04 | 70 | 125 | 5 | MM14916 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 4.23e-04 | 17 | 125 | 3 | M47387 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 4.35e-04 | 110 | 125 | 6 | MM15977 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 5.94e-04 | 19 | 125 | 3 | MM1513 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 5.94e-04 | 19 | 125 | 3 | M47957 | |
| Pathway | REACTOME_INTERFERON_GAMMA_SIGNALING | 5.94e-04 | 19 | 125 | 3 | MM15473 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 7.67e-04 | 5 | 125 | 2 | MM15582 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.05e-03 | 130 | 125 | 6 | M27454 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.06e-03 | 23 | 125 | 3 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.06e-03 | 23 | 125 | 3 | M47512 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.20e-03 | 24 | 125 | 3 | M47509 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.36e-03 | 25 | 125 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.36e-03 | 25 | 125 | 3 | M47511 | |
| Pubmed | FLII ZBTB38 DSCAM MYCBP2 PPRC1 ENPP2 PEG3 ZNFX1 POGZ TRIM68 EXTL3 ARMCX4 SHROOM2 LRP1B PIK3R4 NEFL FBXL16 MORF4L2 CTR9 ZNF451 MAST1 DLG1 DLG4 ATIC DGCR8 PLEC BACE2 SLX4 ZNF292 | 1.71e-11 | 1285 | 177 | 29 | 35914814 | |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 2.82e-10 | 18 | 177 | 6 | 18311135 | |
| Pubmed | 2.48e-09 | 12 | 177 | 5 | 8615909 | ||
| Pubmed | 2.48e-09 | 12 | 177 | 5 | 8665664 | ||
| Pubmed | 2.48e-09 | 12 | 177 | 5 | 12815021 | ||
| Pubmed | 6.22e-09 | 14 | 177 | 5 | 10373510 | ||
| Pubmed | The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1. | 9.30e-09 | 15 | 177 | 5 | 14622581 | |
| Pubmed | 9.30e-09 | 15 | 177 | 5 | 9481670 | ||
| Pubmed | 9.65e-09 | 6 | 177 | 4 | 12166626 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 4.47e-08 | 8 | 177 | 4 | 12634303 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L EPHB4 COL6A1 EOGT MYCBP2 LAMA4 SLC6A15 PSME2 EXTL3 LBR LRP1B SLC38A2 FAT1 MEGF8 LNPEP BTD VPS35 SEL1L3 KIRREL1 ECEL1 TTC13 TMEM231 BACE2 | 5.38e-08 | 1201 | 177 | 23 | 35696571 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLII FLNC EP400 RASA3 MYCBP2 CAMK2D POLE CAMK2G PKP4 POGZ LBR ECH1 TOE1 HNRNPH1 HNRNPH2 PIK3R4 BLVRA IPO9 CTR9 VPS35 PYGL ATIC HSP90AB2P PLEC | 1.11e-07 | 1353 | 177 | 24 | 29467282 |
| Pubmed | A specific N-terminal residue in Kv1.5 is required for upregulation of the channel by SAP97. | 1.30e-07 | 3 | 177 | 3 | 16466689 | |
| Pubmed | Identification of novel human tumor cell-specific CaMK-II variants. | 1.30e-07 | 3 | 177 | 3 | 9060999 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 10819240 | ||
| Pubmed | The human growth hormone gene locus: structure, evolution, and allelic variations. | 1.30e-07 | 3 | 177 | 3 | 3030680 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 20844140 | ||
| Pubmed | EP400 PPRC1 PEG3 POGZ STRIP2 SNX13 MEGF8 ZNF451 MARK4 ARHGEF9 SEL1L3 MAST1 RERE | 1.93e-07 | 407 | 177 | 13 | 12693553 | |
| Pubmed | FLII FLNC NRDC MAP2 CAMK2B CAMK2D CAMK2G PKP4 ZNFX1 CHD3 SHROOM2 HNRNPH1 PIK3R4 NEFL FBXL16 MORF4L2 VPS35 GNB5 MAST1 DLG1 DLG4 PLEC GNAZ HCK | 3.08e-07 | 1431 | 177 | 24 | 37142655 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MAPKAP1 MAP2 MYCBP2 CAMK2D TRIM68 LBR CDC14A PIK3R4 FSIP2 SLC38A2 IPO9 MAST4 KCNA7 MEGF8 MARK4 GAN HELZ PLEC | 4.79e-07 | 861 | 177 | 18 | 36931259 |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 10381553 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 1378436 | ||
| Pubmed | Cadmium activates CaMK-II and initiates CaMK-II-dependent apoptosis in mesangial cells. | 5.16e-07 | 4 | 177 | 3 | 17367784 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 11889801 | ||
| Pubmed | 1.13e-06 | 16 | 177 | 4 | 10882104 | ||
| Pubmed | SEL1L MAPKAP1 MRM2 CAMK2G SAV1 MARCHF7 HEXIM1 CRK NCBP2 SLC38A2 IPO9 SLC15A2 CTR9 VPS35 GNB5 VPS41 HELZ ECEL1 ATIC RERE ZNF292 RAB11FIP3 | 1.21e-06 | 1327 | 177 | 22 | 32694731 | |
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 1.29e-06 | 5 | 177 | 3 | 31479305 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 10767558 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 11013247 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 18006625 | ||
| Pubmed | Growth hormone prevents the development of autoimmune diabetes. | 1.29e-06 | 5 | 177 | 3 | 24218587 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 9546108 | ||
| Pubmed | Transgene transmission to progeny by oMt1a-oGH transgenic mice. | 1.29e-06 | 5 | 177 | 3 | 16201410 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 21209221 | ||
| Pubmed | Genes that prolong life: relationships of growth hormone and growth to aging and life span. | 1.29e-06 | 5 | 177 | 3 | 11487592 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 11318985 | ||
| Pubmed | Identification of the glomerular podocyte as a target for growth hormone action. | 1.29e-06 | 5 | 177 | 3 | 17272398 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 20707609 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 14722083 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 1874564 | ||
| Pubmed | Growth Hormone Deficiency and Excess Alter the Gut Microbiome in Adult Male Mice. | 1.29e-06 | 5 | 177 | 3 | 32100023 | |
| Pubmed | Transgenic mice expressing bovine GH develop arthritic disorder and self-antibodies. | 1.29e-06 | 5 | 177 | 3 | 10810296 | |
| Pubmed | Somatotropin transgenic mice have reduced jejunal active glucose transport rates. | 1.29e-06 | 5 | 177 | 3 | 7965203 | |
| Pubmed | SAP97 increases Kv1.5 currents through an indirect N-terminal mechanism. | 1.29e-06 | 5 | 177 | 3 | 12860415 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 17347312 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 21852148 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 12175649 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 15070902 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 14726450 | ||
| Pubmed | UV photodegradation of murine growth hormone: chemical analysis and immunogenicity consequences. | 1.29e-06 | 5 | 177 | 3 | 24758742 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 10076541 | ||
| Pubmed | Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. | 1.29e-06 | 5 | 177 | 3 | 10594738 | |
| Pubmed | Hypoxia and cytoplasmic alkalinization upregulate growth hormone expression in lymphocytes. | 1.29e-06 | 5 | 177 | 3 | 23639351 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 21098290 | ||
| Pubmed | Age-related changes in body composition of bovine growth hormone transgenic mice. | 1.29e-06 | 5 | 177 | 3 | 18948397 | |
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 1.29e-06 | 5 | 177 | 3 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 1.29e-06 | 5 | 177 | 3 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 1.29e-06 | 5 | 177 | 3 | 16508206 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 15616010 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 1.29e-06 | 5 | 177 | 3 | 32556100 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 1.29e-06 | 5 | 177 | 3 | 11346667 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 12010633 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 18218981 | ||
| Pubmed | Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis. | 1.29e-06 | 5 | 177 | 3 | 17626886 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 19359380 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 15316240 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 17301034 | ||
| Pubmed | Growth hormone action in the developing neural retina: a proteomic analysis. | 1.29e-06 | 5 | 177 | 3 | 18203262 | |
| Pubmed | Assignment of the porcine growth hormone gene to chromosome 12. | 1.29e-06 | 5 | 177 | 3 | 2249485 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 17242167 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 18180319 | ||
| Pubmed | Cloning and characterisation of the GH gene from the common dolphin (Delphinus delphis). | 1.29e-06 | 5 | 177 | 3 | 12225773 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 3780533 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 10395045 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 24190208 | ||
| Pubmed | Brief report: short stature caused by a mutant growth hormone. | 1.29e-06 | 5 | 177 | 3 | 8552145 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 36762426 | ||
| Pubmed | High molecular weight isoforms of growth hormone in cells of the immune system. | 1.29e-06 | 5 | 177 | 3 | 21741628 | |
| Pubmed | Structure of the growth hormone-encoding gene and its promoter in mice. | 1.29e-06 | 5 | 177 | 3 | 8647448 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 26887678 | ||
| Pubmed | Transition from reversible to persistent binding of CaMKII to postsynaptic sites and NR2B. | 1.29e-06 | 5 | 177 | 3 | 16436603 | |
| Pubmed | The role of growth hormone in fetal mouse reproductive tract differentiation. | 1.29e-06 | 5 | 177 | 3 | 8756530 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 31099824 | ||
| Pubmed | Hot spots for growth hormone gene deletions in homologous regions outside of Alu repeats. | 1.29e-06 | 5 | 177 | 3 | 1980158 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 17881271 | ||
| Pubmed | Neural growth hormone implicated in body weight sex differences. | 1.29e-06 | 5 | 177 | 3 | 23861378 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 12759574 | ||
| Pubmed | Growth hormone production and action in N1E-115 neuroblastoma cells. | 1.29e-06 | 5 | 177 | 3 | 19301152 | |
| Pubmed | Adipocyte insensitivity to insulin in growth hormone-transgenic mice. | 1.29e-06 | 5 | 177 | 3 | 11350075 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 18617616 | ||
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 11570960 | ||
| Pubmed | Promoter shuffling has occurred during the evolution of the vertebrate growth hormone gene. | 1.29e-06 | 5 | 177 | 3 | 10974531 | |
| Pubmed | 1.29e-06 | 5 | 177 | 3 | 23428905 | ||
| Pubmed | Cardiac expression of adenine nucleotide translocase-1 in transgenic mice overexpressing bovine GH. | 1.29e-06 | 5 | 177 | 3 | 17761891 | |
| Pubmed | MAPKAP1 FLII MAP2 MYCBP2 CAMK2B CAMK2D CAMK2G ZNFX1 SHROOM2 LRP1B HNRNPH2 CACNG8 GNB5 MRPS5 UBR3 DLG1 HELZ DLG4 PLEC PHACTR1 | 1.62e-06 | 1139 | 177 | 20 | 36417873 | |
| Pubmed | EPHB4 MAPKAP1 MAP2 MYCBP2 POLE PKP4 SLC6A15 LBR ECH1 NDUFV3 SLC38A2 PNPT1 LNPEP CTR9 ZNF451 CLNS1A VPS35 MRPS5 DLG1 KIRREL1 TTC13 SEMA6A TMEM231 | 2.19e-06 | 1487 | 177 | 23 | 33957083 | |
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 12399427 | ||
| Pubmed | GH modulates hepatic epidermal growth factor signaling in the mouse. | 2.56e-06 | 6 | 177 | 3 | 20032199 | |
| Interaction | RLN1 interactions | 1.12e-07 | 93 | 174 | 9 | int:RLN1 | |
| Interaction | TRNT1 interactions | 6.58e-07 | 58 | 174 | 7 | int:TRNT1 | |
| Interaction | PSG8 interactions | 1.33e-06 | 41 | 174 | 6 | int:PSG8 | |
| Interaction | VEGFB interactions | 1.03e-05 | 34 | 174 | 5 | int:VEGFB | |
| Interaction | ANKRD20A4P interactions | 1.24e-05 | 6 | 174 | 3 | int:ANKRD20A4P | |
| Interaction | C6orf141 interactions | 1.50e-05 | 92 | 174 | 7 | int:C6orf141 | |
| Interaction | KALRN interactions | 1.98e-05 | 96 | 174 | 7 | int:KALRN | |
| Interaction | CIBAR2 interactions | 2.16e-05 | 7 | 174 | 3 | int:CIBAR2 | |
| Interaction | CSHL1 interactions | 2.16e-05 | 7 | 174 | 3 | int:CSHL1 | |
| Interaction | ANKRD20A2P interactions | 2.16e-05 | 7 | 174 | 3 | int:ANKRD20A2P | |
| Interaction | DEFB135 interactions | 2.97e-05 | 42 | 174 | 5 | int:DEFB135 | |
| Interaction | CAMK2A interactions | DSCAM MYCBP2 CAMK2B CAMK2D CAMK2G PKP4 ANGEL2 DLG1 DLG4 HSP90AB2P PMFBP1 | 3.22e-05 | 279 | 174 | 11 | int:CAMK2A |
| Interaction | HCK interactions | 4.72e-05 | 193 | 174 | 9 | int:HCK | |
| Interaction | GNG3 interactions | 4.98e-05 | 24 | 174 | 4 | int:GNG3 | |
| Interaction | KCNAB1 interactions | 5.89e-05 | 25 | 174 | 4 | int:KCNAB1 | |
| Interaction | GPHA2 interactions | 5.89e-05 | 25 | 174 | 4 | int:GPHA2 | |
| Interaction | CAMK2N1 interactions | 7.26e-05 | 10 | 174 | 3 | int:CAMK2N1 | |
| Interaction | LYZL1 interactions | 7.47e-05 | 118 | 174 | 7 | int:LYZL1 | |
| Interaction | SYNGAP1 interactions | DSCAM MID2 MAP2 MYCBP2 CAMK2B HNRNPH1 CRK STRIP2 DLG1 DLG4 GNAZ | 7.63e-05 | 307 | 174 | 11 | int:SYNGAP1 |
| Interaction | ANKRD20A1 interactions | 9.92e-05 | 11 | 174 | 3 | int:ANKRD20A1 | |
| Interaction | DYNLL2 interactions | RPGRIP1L ANKRD20A2P POGZ HNRNPH1 STRIP2 ANKRD20A4P NFIA MAST1 DLG4 ANKRD20A1 | 9.99e-05 | 263 | 174 | 10 | int:DYNLL2 |
| Interaction | ITGB4 interactions | 1.07e-04 | 125 | 174 | 7 | int:ITGB4 | |
| Interaction | CFC1 interactions | 1.13e-04 | 126 | 174 | 7 | int:CFC1 | |
| Interaction | PPP2CB interactions | EP400 CAMK2B CAMK2D CAMK2G HNRNPH1 STRIP2 FBXL16 MARK4 MAST1 DLG4 | 1.13e-04 | 267 | 174 | 10 | int:PPP2CB |
| Interaction | ATOSA interactions | 1.31e-04 | 12 | 174 | 3 | int:ATOSA | |
| Interaction | LYPD1 interactions | 1.43e-04 | 58 | 174 | 5 | int:LYPD1 | |
| Cytoband | 17q24.2 | 5.41e-06 | 30 | 177 | 4 | 17q24.2 | |
| GeneFamily | Growth hormone family | 5.21e-06 | 6 | 117 | 3 | 1175 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | ZBTB38 DSCAM MAP2 MYCBP2 CAMK2B PEG3 SHROOM2 LRP1B SLC7A14 CACNG8 FBXL16 CHD5 LRRTM4 MAST1 KIRREL1 PMFBP1 ZNF292 | 5.28e-06 | 703 | 175 | 17 | M39070 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_500 | EXOC6 EOGT MID2 RASA3 TRPC6 LAMA4 LBP SHROOM2 S1PR1 AFAP1L1 MMRN1 SLC15A2 SEMA6A ABCD2 | 6.07e-06 | 409 | 171 | 14 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | PLA2G7 EXOC6 TDRKH MID2 ENPP2 HIPK2 LAMA4 CA14 LBP CDC14A FREM1 SEL1L3 PYGL | 2.16e-05 | 398 | 171 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000 | EPHB4 EXOC6 EOGT MID2 RASA3 TRPC6 LAMA4 LBP ARMCX4 SHROOM2 S1PR1 AFAP1L1 MMRN1 KCNA5 SLC15A2 ARHGEF9 SEMA6A ABCD2 CTSH | 3.40e-05 | 817 | 171 | 19 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000 |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-08 | 187 | 177 | 9 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-08 | 191 | 177 | 9 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL17A1 HNRNPH1 HNRNPH2 CRK SLC38A2 NFIA SERINC1 VPS35 VPS41 | 1.09e-07 | 199 | 177 | 9 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.14e-07 | 200 | 177 | 9 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.28e-07 | 183 | 177 | 8 | 6cbc88c27dc957d182526e84824f70c8e860bf74 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.66e-07 | 190 | 177 | 8 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.09e-06 | 193 | 177 | 8 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 198 | 177 | 8 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-06 | 170 | 177 | 7 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 5.86e-06 | 172 | 177 | 7 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 6.09e-06 | 173 | 177 | 7 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.81e-06 | 176 | 177 | 7 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.33e-06 | 178 | 177 | 7 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-06 | 179 | 177 | 7 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.79e-06 | 183 | 177 | 7 | 91764095f7ea4bc806ef6c7b841fc5e5e90faf5f | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.10e-06 | 184 | 177 | 7 | 1a4297b9d3cc4744bea0408fd5ee7b33ba2a1d78 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 9.10e-06 | 184 | 177 | 7 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 9.10e-06 | 184 | 177 | 7 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 9.43e-06 | 185 | 177 | 7 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.77e-06 | 186 | 177 | 7 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.77e-06 | 186 | 177 | 7 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 188 | 177 | 7 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 188 | 177 | 7 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-05 | 188 | 177 | 7 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 189 | 177 | 7 | 8e583ec4df0f5b79ce5211cc99ecd8616d180bde | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 189 | 177 | 7 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-05 | 190 | 177 | 7 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-05 | 190 | 177 | 7 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-05 | 190 | 177 | 7 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | IPF-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 1.12e-05 | 190 | 177 | 7 | ac029e73da5995221c9b9af551d85e4b835e21d6 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 191 | 177 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 191 | 177 | 7 | f0c649bb32732c9dd38a0af8ce94d2a4d16de39a | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 191 | 177 | 7 | e518c598719119e60c76016c586b1520c258bbcb | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 191 | 177 | 7 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 192 | 177 | 7 | 2ec132a1740e865e7cc0f82ffd4772d43f7ac086 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 192 | 177 | 7 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 1.20e-05 | 192 | 177 | 7 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 192 | 177 | 7 | 3792c53b5d4b759573e1c7bb89ef9b654c9cbfcd | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 192 | 177 | 7 | 64022a47dccd7966777f6741d1c68e298f37ca9d | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.20e-05 | 192 | 177 | 7 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 192 | 177 | 7 | f67a88bd039944d3d7a5a4a9f2e053985075155c | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-05 | 193 | 177 | 7 | 3d4411b3c1cb160dec5db29f0c126d8827dfe185 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 193 | 177 | 7 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 1.24e-05 | 193 | 177 | 7 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-05 | 193 | 177 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 1.28e-05 | 194 | 177 | 7 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 195 | 177 | 7 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 196 | 177 | 7 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 196 | 177 | 7 | fcbfd8c4771d99a45fc53e482ef98edabe8ef591 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-05 | 196 | 177 | 7 | 66ba31b74953726e9c314f6d8fe3f75d3762e23a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 196 | 177 | 7 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-05 | 197 | 177 | 7 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.42e-05 | 197 | 177 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.42e-05 | 197 | 177 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | control-B_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.46e-05 | 198 | 177 | 7 | c012b8fbfa8bbc5014217f47acf9177470d8a65a | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.46e-05 | 198 | 177 | 7 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.51e-05 | 199 | 177 | 7 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-05 | 199 | 177 | 7 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 199 | 177 | 7 | a9c2041e54899cb8ccc026758647f3ae3ca457dd | |
| ToppCell | ILEUM-inflamed-(7)_Endothelial_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.51e-05 | 199 | 177 | 7 | 97052c28e354833901f28d339b09f97f50a5b752 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-05 | 199 | 177 | 7 | 1587d24b19f5bb64a3b6cc1df87c7c472cf41672 | |
| ToppCell | Biopsy_Other_PF-Endothelial-Lymphatic_Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.51e-05 | 199 | 177 | 7 | aa80c77fe4f6a141c780c7d8ecfff5d5a1c3b845 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-05 | 199 | 177 | 7 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.51e-05 | 199 | 177 | 7 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 177 | 7 | b515b2ab0c3f5928dd67f2f227fc932451c272bb | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Lymphatic_Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.56e-05 | 200 | 177 | 7 | 8cf218887ab030b7625610cb65b595170a17ebec | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 200 | 177 | 7 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 177 | 7 | e50ef394e3284a8323bfd60575b262b2be422aea | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 177 | 7 | 35f6c7f2469d12748c27f2a5d4a161ef839b4a07 | |
| ToppCell | Control-Control-Lymphocyte-B-B_naive|Control / Disease, condition lineage and cell class | 1.56e-05 | 200 | 177 | 7 | 15e4b9956b9a0c2e6927a802e86e1cb4bb18b89a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 177 | 7 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 177 | 7 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 177 | 7 | c59f262b2b0a7e7dcb2940d1e466f98db6c56625 | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 2.07e-05 | 140 | 177 | 6 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | Mild/Remission-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.24e-05 | 142 | 177 | 6 | fc5fc2d2b4b976358b8ce762c1f440b20db84103 | |
| ToppCell | Mild/Remission-B_naive-5|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.83e-05 | 148 | 177 | 6 | 8b60f9843505660b3c9d5c7792976f902be4b94c | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.94e-05 | 149 | 177 | 6 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.69e-05 | 162 | 177 | 6 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.02e-05 | 164 | 177 | 6 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.19e-05 | 165 | 177 | 6 | 62457b7b74c6eae42d91d65e7dc6df6bf8e061f7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-05 | 166 | 177 | 6 | da10d0be6b616199d49dd922591c2901f9681583 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.55e-05 | 167 | 177 | 6 | 013971700e80b71e4b8c79b8fff0d8beeac295c3 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-05 | 169 | 177 | 6 | c6e5b179461996ced6c7621dc01cec00d401f4e8 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-05 | 169 | 177 | 6 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.33e-05 | 171 | 177 | 6 | 23b3120706bb9c20b9214fe3760c6d7a84f1e749 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-05 | 171 | 177 | 6 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | Endothelial-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.33e-05 | 171 | 177 | 6 | 07ff7059071da83da1d8f266a586573920d75b58 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.54e-05 | 172 | 177 | 6 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.54e-05 | 172 | 177 | 6 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.75e-05 | 173 | 177 | 6 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.97e-05 | 174 | 177 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-05 | 175 | 177 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-05 | 177 | 177 | 6 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D175|Adult / Lineage, Cell type, age group and donor | 7.66e-05 | 177 | 177 | 6 | c9f269765c7d5d29caab75910e51645606ed562e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-05 | 178 | 177 | 6 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.15e-05 | 179 | 177 | 6 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.40e-05 | 180 | 177 | 6 | 178648429686e6d4e6f3aafc350130e819788ecf | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.40e-05 | 180 | 177 | 6 | c2a8f61c806f6f6f47743e9f7c9700705db43386 | |
| ToppCell | facs-Lung-24m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.40e-05 | 180 | 177 | 6 | fcd5d5bf00ee728162b0aac4c81eb78e742cf6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-05 | 181 | 177 | 6 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.71e-06 | 194 | 175 | 10 | 4219_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.71e-06 | 194 | 175 | 10 | 1707_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 2.83e-06 | 195 | 175 | 10 | 2264_DN | |
| Drug | Chloramphenicol [56-75-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | TDRKH RPGRIP1L CAMK2B TRPC6 LIG4 MAST4 BTD ANGEL2 MARK4 RAB11FIP3 | 2.97e-06 | 196 | 175 | 10 | 5466_UP |
| Drug | PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.77e-05 | 191 | 175 | 9 | 7086_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 2.01e-05 | 194 | 175 | 9 | 4559_DN | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.09e-05 | 195 | 175 | 9 | 6244_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 2.26e-05 | 197 | 175 | 9 | 3364_UP | |
| Drug | Triflusal [322-79-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.36e-05 | 198 | 175 | 9 | 7451_UP | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; HL60; HT_HG-U133A | SEL1L FLII COL6A1 RASA3 HIPK2 ARHGEF9 DLG1 PHACTR1 RAB11FIP3 | 2.36e-05 | 198 | 175 | 9 | 1859_UP |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 1uM; PC3; HT_HG-U133A | MAP2 CAMK2B PEG3 IL20RA CDC14A ARHGEF9 SEMA6A PRDM14 RAB11FIP3 | 2.36e-05 | 198 | 175 | 9 | 4562_UP |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.36e-05 | 198 | 175 | 9 | 5295_UP | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; PC3; HT_HG-U133A | 2.36e-05 | 198 | 175 | 9 | 6304_UP | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 1.80e-06 | 5 | 168 | 3 | DOID:0060872 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 6.24e-06 | 7 | 168 | 3 | DOID:0060870 (implicated_via_orthology) | |
| Disease | Meckel syndrome (implicated_via_orthology) | 9.94e-06 | 8 | 168 | 3 | DOID:0050778 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 6.30e-05 | 14 | 168 | 3 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 7.84e-05 | 15 | 168 | 3 | C0265215 | |
| Disease | posterior thigh muscle volume | 7.84e-05 | 15 | 168 | 3 | EFO_0020931 | |
| Disease | cortical surface area measurement | EXOC6 MAP2 MYCBP2 ENPP2 HIPK2 MARCHF7 SLC6A15 EXTL3 S1PR1 HNRNPH1 SNX13 AFAP1L1 BLVRA SLC38A2 MAST4 KCNA5 NFIA SEMA6A RERE SPAG17 | 8.59e-05 | 1345 | 168 | 20 | EFO_0010736 |
| Disease | frontotemporal dementia (is_marker_for) | 9.63e-05 | 3 | 168 | 2 | DOID:9255 (is_marker_for) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.16e-04 | 17 | 168 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Meckel syndrome type 1 | 1.39e-04 | 18 | 168 | 3 | C3714506 | |
| Disease | nephrotic syndrome type 2 (is_implicated_in) | 1.92e-04 | 4 | 168 | 2 | DOID:0080379 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | FLNC MAP2 POLE PEG3 CDC14A FAT1 CHD5 GNB5 SPAG17 ABCD2 KDF1 CTSH ZNF292 | 2.04e-04 | 702 | 168 | 13 | C0009402 |
| Disease | osteoporosis (biomarker_via_orthology) | 2.58e-04 | 22 | 168 | 3 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 2.58e-04 | 447 | 168 | 10 | C3714756 | |
| Disease | myeloid white cell count | RASA3 TRPC6 SH3BP1 CDC14A CRK SNX13 RRAGC IFIH1 NFIA LNPEP MARK4 KIRREL1 RERE SPAG17 ZNF292 | 3.19e-04 | 937 | 168 | 15 | EFO_0007988 |
| Disease | Early Pregnancy Loss | 4.09e-04 | 109 | 168 | 5 | C3830362 | |
| Disease | Spontaneous abortion | 4.09e-04 | 109 | 168 | 5 | C0000786 | |
| Disease | Miscarriage | 4.09e-04 | 109 | 168 | 5 | C4552766 | |
| Disease | Abortion, Tubal | 4.09e-04 | 109 | 168 | 5 | C0000822 | |
| Disease | lymphocyte percentage of leukocytes | EXOC6 ZBTB38 RASA3 S1PR1 HNRNPH1 CRK MORF4L2 LNPEP MARK4 HELZ RERE ZNF292 | 4.51e-04 | 665 | 168 | 12 | EFO_0007993 |
| Disease | Polydactyly | 5.65e-04 | 117 | 168 | 5 | C0152427 | |
| Disease | Familial aplasia of the vermis | 6.57e-04 | 30 | 168 | 3 | C0431399 | |
| Disease | autoimmune thyroid disease | 7.90e-04 | 126 | 168 | 5 | EFO_0006812 | |
| Disease | heart conduction disease (implicated_via_orthology) | 7.96e-04 | 32 | 168 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | DSCAM CAMK2D TRPC6 MARCHF7 FREM1 FSIP2 EYS MAST4 KCNA5 MARK4 CNPY1 | 8.82e-04 | 619 | 168 | 11 | EFO_0003923, EFO_0004531 |
| Disease | benign neoplasm (implicated_via_orthology) | 8.82e-04 | 8 | 168 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 1.09e-03 | 277 | 168 | 7 | C0009404 | |
| Disease | diffuse plaque measurement | NRDC CAMK2D PKP4 SERPINA6 ECH1 LRP1B STRIP2 RRAGC EYS MAST4 HSP90AB2P RERE | 1.40e-03 | 758 | 168 | 12 | EFO_0010699 |
| Disease | Meckel-Gruber syndrome | 1.41e-03 | 10 | 168 | 2 | cv:C0265215 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 1.43e-03 | 39 | 168 | 3 | DOID:9744 (implicated_via_orthology) | |
| Disease | kidney disease (implicated_via_orthology) | 1.65e-03 | 41 | 168 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | response to ondansetron, QT interval | 1.71e-03 | 11 | 168 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 1.71e-03 | 11 | 168 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | kidney cancer (implicated_via_orthology) | 1.71e-03 | 11 | 168 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.00e-03 | 93 | 168 | 4 | C1535926 | |
| Disease | left ventricular systolic function measurement | 2.02e-03 | 44 | 168 | 3 | EFO_0008206 | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.05e-03 | 12 | 168 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Behavior Disorders | 2.05e-03 | 12 | 168 | 2 | C0004930 | |
| Disease | Mental disorders | 2.05e-03 | 12 | 168 | 2 | C0004936 | |
| Disease | Mental Disorders, Severe | 2.05e-03 | 12 | 168 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 2.05e-03 | 12 | 168 | 2 | C0376338 | |
| Disease | Adenocarcinoma of large intestine | 2.24e-03 | 96 | 168 | 4 | C1319315 | |
| Disease | skin and soft tissue Staphylococcus aureus infection | 2.41e-03 | 13 | 168 | 2 | EFO_1001489 | |
| Disease | neutrophil percentage of leukocytes | 2.70e-03 | 610 | 168 | 10 | EFO_0007990 | |
| Disease | lifestyle measurement, depressive symptom measurement | 3.10e-03 | 105 | 168 | 4 | EFO_0007006, EFO_0010724 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 3.22e-03 | 15 | 168 | 2 | OBA_2045067 | |
| Disease | electrocardiography | 3.47e-03 | 530 | 168 | 9 | EFO_0004327 | |
| Disease | coronary artery disease | EXOC6 TDRKH DSCAM VWDE SNX13 IFIH1 MAST4 CASTOR1 NFIA LNPEP BTD MARK4 KDF1 PMFBP1 PHACTR1 | 3.52e-03 | 1194 | 168 | 15 | EFO_0001645 |
| Disease | Metastatic melanoma | 3.63e-03 | 54 | 168 | 3 | C0278883 | |
| Disease | response to darapladib, Diarrhea | 3.67e-03 | 16 | 168 | 2 | EFO_0008395, HP_0002014 | |
| Disease | pneumonia, COVID-19 | 4.03e-03 | 113 | 168 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | Vitiligo | 4.14e-03 | 17 | 168 | 2 | C0042900 | |
| Disease | neutrophil-to-lymphocyte ratio | 4.24e-03 | 185 | 168 | 5 | EFO_0008447 | |
| Disease | cancer (implicated_via_orthology) | 4.46e-03 | 268 | 168 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Hypermetropia, Myopia | 4.63e-03 | 189 | 168 | 5 | HP_0000540, HP_0000545 | |
| Disease | vital capacity | EPHB3 ZBTB38 MAP2 ENPP2 CAMK2B CAMK2G SLC6A15 SNX13 AFAP1L1 PNPT1 NFIA LRRTM4 DLG1 HSP90AB2P PMFBP1 | 4.83e-03 | 1236 | 168 | 15 | EFO_0004312 |
| Disease | Liver Cirrhosis, Experimental | COL6A1 ENPP2 CAMK2D LBP PSME2 SERPINA6 S1PR1 HEXIM1 BLVRA FAT1 HCK | 4.95e-03 | 774 | 168 | 11 | C0023893 |
| Disease | refractive error, age at onset, Myopia | 5.06e-03 | 193 | 168 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 5.12e-03 | 61 | 168 | 3 | C1961102 | |
| Disease | colorectal cancer (is_implicated_in) | 5.14e-03 | 121 | 168 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | Lewy body dementia (is_marker_for) | 5.17e-03 | 19 | 168 | 2 | DOID:12217 (is_marker_for) | |
| Disease | neutrophil count | DSCAM MYCBP2 MARCHF7 CA14 POGZ CDC14A CRK SNX13 RRAGC IFIH1 PPT2 LNPEP MARK4 KIRREL1 RERE ZNF292 | 5.68e-03 | 1382 | 168 | 16 | EFO_0004833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DRVHFPASTDYSTQY | 1146 | Q99569 | |
| ALHYAVYSESTSLAE | 136 | Q5TYW2 | |
| EYLADLYHFVTKEDS | 216 | Q6ZT62 | |
| DYSELASHVVSYLRT | 1056 | Q9UMD9 | |
| NAFTDYDVIHLKTYD | 291 | Q5NDL2 | |
| FHYLTYVRIDENASS | 1936 | Q96L91 | |
| TPHSYIDTYFDTERS | 121 | Q9Y5Z0 | |
| SHDYSLYSLDVEFIN | 166 | Q5SQH8 | |
| ALHYAVYSESTSLAE | 136 | Q5CZ79 | |
| LSNDSIIHEVFIDYY | 491 | Q5SY80 | |
| VDYLFSEEDYHTLTN | 146 | Q8TDI0 | |
| SEEDYHTLTNYKAFS | 151 | Q8TDI0 | |
| RTRLVDHAYETYFTN | 176 | Q9UBJ2 | |
| ADISAYYISTFNFDH | 291 | Q8WTX7 | |
| TVNTHYFSIDEELVY | 31 | Q9UNH5 | |
| ALHYAVYSESTSLAE | 136 | Q4UJ75 | |
| RDYEVDGRDYHFVTS | 751 | Q12959 | |
| ALHYAVYSESTSLAE | 136 | A0PJZ0 | |
| ADLYHFVTKEDSYAN | 211 | Q9Y3L3 | |
| NLVYDTSDSDDYHLL | 131 | Q14406 | |
| HSRSAITVDYIFYSA | 471 | Q5VTE6 | |
| EYFNHISIEDSRVYE | 596 | Q8WYQ5 | |
| LYNSADYSYSHEVVR | 2066 | Q5H9R4 | |
| AQDHSDYRYVAAALA | 261 | O43307 | |
| DYVLSVSENSRVSHY | 46 | P46108 | |
| DLYLAYFVHAADSSQ | 176 | Q12857 | |
| NVVYTEDHVFSSDYY | 286 | Q14644 | |
| DFVTYEANEVTDSAY | 296 | O75154 | |
| AFETHESDINSVRYY | 276 | O14775 | |
| LYYEVEILSHDSTSQ | 21 | Q14739 | |
| SAYVAASEVHYSTRN | 426 | P0C860 | |
| ASVVFSTLFIAYYDH | 171 | Q01726 | |
| ALHYAVYSESTSLAE | 136 | Q5SQ80 | |
| VVTVHYSLNSEAYED | 426 | Q6IE37 | |
| ENLDYESSHEYYLTV | 3291 | Q14517 | |
| SYEHNSESYLLREHV | 611 | A0AUZ9 | |
| ISDYVFNTASLVYHE | 281 | P18428 | |
| ASGFYTVEDTHYVTR | 606 | Q13045 | |
| STESADDYNFVRAYE | 251 | Q9H2X6 | |
| LDFHAETNYIYFADT | 561 | Q9NZR2 | |
| AYSRISDISFHYEFH | 2431 | Q5T1H1 | |
| YLDHNYISSVDEDAF | 91 | Q86VH4 | |
| SDSYVELSQYRDQHF | 11 | P52298 | |
| FTVFYYESDADTATA | 111 | P54760 | |
| EVHQAYSTEYETIAA | 681 | Q68CZ1 | |
| ALEQEHSRSILYYES | 491 | Q13201 | |
| DHLAVRYFSVEEYVS | 236 | Q58FF8 | |
| NLVYDTSDSDDYHLL | 126 | P0DML3 | |
| EIYTHFSLIIDDTEY | 5581 | Q5CZC0 | |
| DFSETYERYHTESLQ | 266 | O94992 | |
| AYDHSYVELFLNSTA | 371 | P55795 | |
| SAFLEETGYDTYVHD | 551 | Q86V87 | |
| YSRDHSVAESLNYVA | 281 | Q13011 | |
| RDFEIIDNHDYSYTV | 916 | Q14315 | |
| LHFIDSESYDRELVY | 666 | Q5H8C1 | |
| SAVYHEATDSLYVFG | 1676 | Q7Z7M0 | |
| FTASDYKVASAEYHR | 271 | Q15014 | |
| NLFYYEADSDVASAS | 131 | P54753 | |
| TYLSEDVFQHAVVLY | 561 | Q9UIQ6 | |
| DYIRFTEFIEQYTGH | 51 | Q9UGJ1 | |
| TYESIFSHFREYEIA | 156 | Q13651 | |
| EDAIAYVEYITSSIH | 1881 | Q07864 | |
| AYEHRYVELFLNSTA | 371 | P31943 | |
| TVHYSLNSEAYEDDS | 456 | Q6IE36 | |
| YRSHEAIINYTSELF | 866 | P42694 | |
| HYRSVFYSFEEQHIS | 1171 | Q3BBV0 | |
| SLTAHYDEFQEVKYV | 6 | O95672 | |
| HIYSVLGDEETFENY | 291 | Q8TAG9 | |
| RENLYEYGESFIHSV | 476 | Q9GZU2 | |
| DLSAETSDYEHQYYA | 96 | Q9UHF4 | |
| RYHHVNSYDEDDTTE | 681 | Q9Y2H9 | |
| AVEHRDRSASATYYF | 176 | Q13093 | |
| HESDYEDSSCLYTRE | 381 | Q9C0D0 | |
| FDSSYSFRHLLEYIN | 46 | Q9UMR5 | |
| REAETDNLDHYTNAY | 61 | Q5SZD4 | |
| ALHYAVYSESTSLAE | 136 | Q5VUR7 | |
| TDYDHDSAEYLLRVV | 111 | Q8WXS5 | |
| YIQSVLDDFYTATES | 506 | P08631 | |
| TFYTYEEGLSHLTAE | 166 | P54105 | |
| FSRSSEYHLEDNAAY | 141 | P19086 | |
| VSNFNYFYHRETDHE | 516 | P22460 | |
| NFSYFYHRETEGEEA | 396 | Q96RP8 | |
| YYTDTSQKEAFHLEA | 1006 | P20023 | |
| HTVYLDSYAVINDLS | 816 | P49917 | |
| TAEYDVAYGESHLFR | 991 | P12109 | |
| FSEEDYHTLTNYKAF | 151 | Q12873 | |
| ADSFHYHTLEEAKEY | 621 | Q9H6X5 | |
| IAHYYLTTLDEADEA | 46 | O43909 | |
| YLATEYLETHFRDVS | 151 | Q9H2C0 | |
| DAYTHLETFYNEEKD | 621 | Q9BYX4 | |
| EHDEHYYNAISVTTS | 486 | Q6PD62 | |
| ASLFHVSNDYSFIRY | 501 | Q9BYF1 | |
| EESVADHHEAEYYVA | 46 | P43251 | |
| YEDEISSLIAQETHY | 56 | Q3B7I2 | |
| AYICSESSSHEDYIR | 71 | P53004 | |
| YSTEEYHHRLQTFAS | 46 | P09668 | |
| REYEIDGRDYHFVSS | 571 | P78352 | |
| TYHSRDSSFRLDSEY | 36 | Q9H992 | |
| EYASAGEVFDYLVSH | 136 | Q96L34 | |
| DDTSYFDTRSEKYHH | 866 | O15021 | |
| SAAFYVRTEVNYTEE | 301 | Q96P70 | |
| DAHESRYETNVDYSF | 266 | Q96J84 | |
| LFDAVYASDRATFHT | 256 | O75521 | |
| FAELHIVHYDSDSYD | 131 | Q9ULX7 | |
| IVHYDSDSYDSLSEA | 136 | Q9ULX7 | |
| NLVYDTSDSDDYHLL | 126 | P0DML2 | |
| TSYYQDQVDDFHEAR | 41 | Q9NQZ2 | |
| HAEERTRYFSVFYLS | 176 | Q16348 | |
| AHRSSVSDYVNYDII | 11 | P21453 | |
| HLSDFEAYYSDIQEA | 1066 | Q8TDX9 | |
| VTYRYAEEAFAAIES | 1586 | Q5VV67 | |
| ESFSADIKHYYESEV | 141 | P08185 | |
| DILYHTDFESGYSEI | 611 | Q13822 | |
| DIVAREYYSEADASH | 101 | Q13555 | |
| HIGTTEEYLFYFTSD | 371 | O14772 | |
| DIVAREYYSEADASH | 101 | Q13557 | |
| YASDHDIIVSIFYTI | 296 | Q8NGG3 | |
| EDFQRYTEKVHTSLY | 1386 | Q16363 | |
| VHDNSDDFQIYFSTE | 596 | Q6ZN16 | |
| ELEFHTEELQTSYYS | 96 | Q8TBY8 | |
| SASSTYEELARAYEH | 1806 | O60469 | |
| QAYHVTDTALAYFTA | 276 | Q8N461 | |
| YIERYEDHTIFHDIS | 281 | P82675 | |
| DIVAREYYSEADASH | 101 | Q13554 | |
| DDSVQLHAYISDTVY | 556 | Q9Y5W8 | |
| STVTAEDYHLVYDII | 396 | Q9H2J7 | |
| FYNVTDRSHIYTFTD | 471 | Q9HCM9 | |
| YLTSIYDHSIFEAFS | 216 | Q9HB90 | |
| YRDDYFIRHSISVSA | 156 | Q68CR1 | |
| YGHYRNSLATVEEDF | 36 | Q9GZV8 | |
| HAAELSELYSYTENL | 61 | Q9ULQ0 | |
| FGTDVDYETAFIHYR | 641 | Q9UBV2 | |
| DYETAFIHYRLASEQ | 646 | Q9UBV2 | |
| YRSVFYSFEEEHISF | 3801 | A0A087WUL8 | |
| YSFEEEHISFALYLD | 3806 | A0A087WUL8 | |
| QYRSSLYSEVDVHFR | 596 | Q7Z3K3 | |
| HDYKHLYFESDAATV | 461 | Q9BPZ7 | |
| YLSEESLADYEHFVK | 1566 | Q13796 | |
| RSAEQAVYHSIDAYF | 386 | A6NM43 | |
| YSKEDYSVVNRFESH | 1226 | O75592 | |
| AFYAELYHIISSNLE | 211 | Q9UL46 | |
| ELFISDYVDTYHAAA | 226 | Q9P2R6 | |
| LYDHTTILFAAEVFY | 291 | Q9BUU2 | |
| RGSEEYYSFHESDLD | 211 | Q8NAX2 | |
| YAVFTDYEHDKVSRD | 296 | Q8TCS8 | |
| DNERDGVTYSYSFFH | 376 | Q9NRX5 | |
| DHADGTRITTFYQVY | 1451 | Q6Q759 | |
| EAARTFLHYLYTADT | 746 | Q8IY92 | |
| HYDYVDVETLTSIVS | 521 | Q8TED9 | |
| VESYFSDIHDFEYDK | 16 | Q99570 | |
| EALHQSTYQRYDVDD | 686 | Q8TBB6 | |
| ERVESSEFGTYYVDH | 241 | Q9H4B6 | |
| SHTFVYYTAVTDFSR | 371 | Q8N2E2 | |
| YEEHHSIDYVFVSEK | 686 | Q9Y4E5 | |
| GTLYFISEDYATAHE | 256 | Q8NBP0 | |
| FVDYEAHDISFYNVT | 426 | Q6AZZ1 | |
| SFHADEYLEVYVSAS | 301 | Q9Y2W6 | |
| FTYTDSDRYTNLEEH | 126 | Q9NXB0 | |
| LRNEDYHDYSSTDVS | 6 | Q7Z2H8 | |
| YEHVESELLHTYSSI | 351 | Q96QD8 | |
| SDELHYLEVYLTDEF | 71 | Q96QK1 | |
| IYTVDIDTSHTEEIY | 76 | Q9H2E6 | |
| YDQFDESSVESLFHQ | 136 | Q14586 | |
| SFTTYLNYVVHLEAD | 2226 | O60281 | |
| ISITLTDEGYEHFYE | 506 | O43847 | |
| SSDHTRVDEYYIEDT | 46 | Q6PIZ9 | |
| QEYVDLRTHYSELTT | 1451 | Q15149 | |
| HTAQYDEAISDYFRK | 181 | P31939 | |
| HLEYSEGESLFYIVS | 336 | P49754 | |
| ESSEVYFLATQYHGR | 226 | Q9UI43 | |
| DYYELSDTRESVHES | 591 | P11137 | |
| VETTAYFEAYRHVLE | 506 | Q9P2E3 | |
| TSPFAYDYDLTHIVA | 201 | Q9H6L2 | |
| ELNEHVEFESQTYYA | 556 | Q6ZT12 | |
| LHEFLTSAYEDYDIV | 166 | Q8WVY7 | |
| HSYAVSSVAEAYRSQ | 221 | Q8NAP3 | |
| FYAYDEDGTRFSHDV | 206 | Q9Y210 | |
| DDEFSISSYELQYTI | 426 | Q9UJV3 | |
| VATTRDYYFALAHTV | 46 | P06737 | |
| YAAEFHARFVASYLE | 231 | Q96GM8 | |
| FYAYDEDGTRFSHDI | 151 | Q9HCX4 | |
| FVSYRDYQSDGRSHT | 171 | Q8TDC0 | |
| HHDYSTYTFLDLNLE | 76 | P56181 | |
| TRSFPSYYTSHVQEE | 436 | P07196 |